Press release
June 10, 2026
Parabilis Medicines Announces Pricing of Upsized Initial Public Offering
Parabilis Medicines, Inc. (PBLS)
CAMBRIDGE, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines, Inc. (Nasdaq: PBLS) (“Parabilis”), a clinical-stage biopharmaceutical company built to develop transformative medicines addressing some of the most consequential, yet historically undruggable, protein targets driving human